Statistician for Medical Research

Statistician for medical researchers: survival analysis (Cox), logistic regression, ROC curves, meta-analysis and reviewer responses. PhD theses and Q1/Q2.

Statistics for clinical research that survives peer review in indexed journals

PhD theses, Q1/Q2 articles and reviewer responses in medicine, clinical trials, epidemiology and observational studies. Cox, logistic regression, ROC, meta-analysis and multilevel models: always with methodology that holds up to reviewer 2 and STROBE.

What I see most from clinical research teams

Almost every project comes in with one of these three pain points. If any sounds familiar, we are a fit.

Reviewer asks for multivariate regression

You submitted the manuscript and reviewer 2 demands a logistic or Cox regression that wasn't in your plan. Major revision deadline ticking.

Survival data and clinical events

You have longitudinal follow-up with events (mortality, relapse, drop-out) and don't know whether the right model is Kaplan-Meier, Cox or competing risks.

STROBE / CONSORT requires more than you have

The journal requires STROBE or CONSORT reporting with adjusted analyses, sensitivity, multiple imputation and specific comparisons. Everything must fit in weeks.

Techniques and designs I cover regularly

What any indexed medical journal expects. If your design isn't listed and is quantitative, get in touch: it almost always fits.

Survival analysis (Kaplan-Meier, Cox, competing risks)

Survival curves, adjusted hazard ratios, proportional-hazards assumption, models for multiple events.

Logistic regression (uni and multivariate)

Models for binary outcomes, adjusted ORs, goodness of fit, model diagnostics.

ROC curves and diagnostic accuracy

AUC with 95% CI, curve comparison (DeLong), positive/negative predictive value, Youden index.

Meta-analysis and systematic reviews

Forest plots, heterogeneity (I², τ²), random-effects models, publication bias (Egger, funnel) and meta-regression.

Randomized clinical trials (RCT)

Intent-to-treat and per-protocol analyses, ANCOVA with baseline, mixed models for repeated measures, full CONSORT reporting.

Observational and cohort studies

Propensity score matching, confounder adjustment, non-random missing data and full STROBE reporting.

I work by project, not by the hour

No clock running on your tab. We agree on scope, timeline and a fixed price upfront: no inflated hours, no surprise invoice at the end. Before delivery, every analysis goes through a careful review on my side: I rerun the code, re-check the assumptions and review tables and figures line by line. That's the part I obsess over: that what you receive is ready to defend without errors surfacing in peer review. If something out of scope appears, we discuss it before I touch it.

From your initial doubt to manuscript submitted

Meta-analysis: forest plot with pooled effect

Illustrative example: forest plot with per-study odds ratios, 95% CI, heterogeneity (I²) and the pooled-effect diamond. The kind of figure I deliver ready for a systematic review or clinical article.

Guides and tools for your clinical research

Free resources on the analyses that appear most in medical and clinical research.

Tell me about your clinical research project

Fill out the form telling me the design, the phase you are in and what the journal or supervisor demands. I respond within 24h with a tentative proposal.

Biostatistics and statistical consulting for health research · All services

Frequently asked questions

Do you handle identifiable or sensitive clinical data?

Yes, under NDA when needed. I always recommend you send the data pseudonymized: I explain how to prepare it so GDPR is covered. Data is encrypted on my end and deleted after project completion.

My journal requires STROBE/CONSORT/PRISMA reporting. Can you cover it?

Yes. I have worked with manuscripts submitted to journals that require STROBE (observational), CONSORT (trials) and PRISMA (systematic reviews). I deliver the full checklist, tables and flow diagram.

I have a clinical trial with small N (50-100 patients). Is a publishable analysis viable?

Many medical specialty trials publish with N of 50-100. The key is the analytical design: ANCOVA with baseline instead of change comparison, mixed models for repeated measures, confidence intervals alongside p-values, and transparent reporting of limitations.

Can you help me with reviewer 2 responses?

It's one of the most requested services. I review the reviewer's letter, run additional analyses and help you draft the point-by-point response. Typical turnaround: 48-72h.

You may also be interested in

Home · Contact for a quote